2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 31540262 | CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma. | 2019 Sep 13 | 1 |
| 2 | 25563977 | Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1). | 2015 Jul | 1 |